Good morning :)
Switch to
Place Order

Lincoln Pharmaceuticals Ltd

LINCOLN
Health CarePharmaceuticals
SmallcapWith a market cap of ₹745 cr, stock is ranked 1,034
Moderate RiskStock is 2.65x as volatile as Nifty
372.752.85 (+0.77%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹745 cr, stock is ranked 1,034
Moderate RiskStock is 2.65x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
11.98
PB RatioPB Ratio
2.38
Dividend YieldDiv. Yield
0.40%
Sector PESector PE
40.61
Sector PBSector PB
5.75
Sector Div YldSctr Div Yld
0.62%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Lincoln Pharmaceuticals Limited (LPL) is engaged in the business of manufacturing, marketing and distribution of pharmaceutical products.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021366.07371.78397.53429.8534.6448.7151.4262.22
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 4.37%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Updates 
Announced OnJul 9, 2021

Lincoln Pharmaceuticals Limited has informed the Exchange regarding 'Certificate required under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018'. | Download

Lincoln Pharmaceuticals Limited has informed the Exchange regarding 'Certificate required under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018'. | Download

Copy of Newspaper Publication 
Announced OnJun 22, 2021

Lincoln Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication as required under Rule 6 of IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 and amendments thereof, inviting attention of concerned shareholders to lodge their claims in respect of unclaimed dividends for last seven consecutive years, failing which their shares would be transferred to IEPF Authority. | Download

Lincoln Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication as required under Rule 6 of IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 and amendments thereof, inviting attention of concerned shareholders to lodge their claims in respect of unclaimed dividends for last seven consecutive years, failing which their shares would be transferred to IEPF Authority. | Download

Cash Dividend 
Ex. DateMar 5, 2020

Interim • Div/Share: ₹ 1.5

See all events